Ukraine strikes back: Fighting fire with fire against Russian invasion
Ukrainian forces are persistently launching a counteroffensive against Russian occupation in the southeast, with recent triumphant conquests marking their progress, notably the village of Staromaiorske. ... Read More
SBI Life Insurance registers significant growth in new business premium
SBI Life Insurance, a premier life insurance provider in India, recorded a New Business Premium of Rs. 6,207 crores in the period ending 30th June ... Read More
Tata Capital to empower entrepreneurs with convenient business loans
With Tata Capital’s business loans, Indian entrepreneurs are receiving a significant boost. These loans, available to a diverse range of business entities, aid in capturing ... Read More
Revealed: Modi govt’s master stroke to quell rising tensions in Manipur
In a glimmer of hope amid the turmoil in Manipur, government sources project a resolution in sight for the ongoing crisis. The law and order ... Read More
Takeda halts TAK-994 narcolepsy treatment development due to hepatotoxicity concerns
Takeda's pioneering Phase 2 trial of TAK-994, a potential treatment for narcolepsy type 1 (NT1), came to an abrupt halt due to hepatotoxicity concerns, according ... Read More
Who’s winning the war? Ukraine-Russia battlefield reports spark confusion
In a chilling development that has the world on edge, Russia's President, Vladimir Putin, accused Ukraine of escalating attacks on the frontline on Wednesday. This ... Read More
Bullet on the soccer field: Personal feud ends in shocking murder in DC
In a shockingly grim event in Northwest Washington, DC, a man's life was brutally cut short by a fatal gunshot at a soccer field in ... Read More
Upgrade acquires travel BNPL provider Uplift in $100m deal
Upgrade, Inc., a fintech firm renowned for offering affordable credit and mobile banking solutions, today reported its acquisition of Uplift, Inc., a top-tier provider of ... Read More
Eli Lilly’s Tirzepatide triumphs in Phase 3 weight loss studies
Eli Lilly and Company has unveiled the results of two Phase 3 tirzepatide studies (SURMOUNT-3 and SURMOUNT-4) targeting adults with obesity or overweight with weight-related ... Read More
Gilead’s Trodelvy gains EC approval as new hope for metastatic breast cancer patients
In a significant advancement for cancer treatment, the European Commission (EC) has approved Gilead Sciences' Trodelvy (sacituzumab govitecan) for the treatment of adult patients suffering ... Read More